Abstract
PURPOSE: To investigate the clinical features that predict growth and metastasis of an unselected group of small melanocytic choroidal tumors. METHODS: A retrospective review was performed on 1329 patients with small melanocytic choroidal tumors measuring 3 mm in thickness or less. Clinical parameters of the patient and tumor were extracted and analyzed for their relationship to eventual tumor growth and metastasis using a Cox proportional hazards regression model. RESULTS: Tumor growth was documented in 18% of patients. The factors predictive of tumor growth (multivariate analysis) included greater tumor thickness, posterior tumor margin touching optic disc, symptoms of flashes, floaters, and blurred vision, orange pigment on the tumor surface, and the presence of subretinal fluid. The relative risk (rr) was greatest for initial tumor thickness > 2.0 mm (rr 5.2) and posterior margin touching the optic disc (rr 2.6). After adjusting for significant tumor variables, the effect of interventional tumor treatment showed a decreasing risk for tumor growth as compared to continued observation without treatment. Of 1329 patients, 35 (3%) developed metastases. The factors predictive of metastases (multivariate analysis) included: posterior tumor margin touching the optic disc, documented growth, and greater tumor thickness. The relative risk for metastases was greatest for tumor thickness 1.1-3.0 mm (rr 8.8) and growth (rr 3.2). CONCLUSION: Of small choroidal melanocytic tumors measuring 3 mm or less in thickness at the time of initial examination, 18% demonstrate growth and 3% metastasize during the period of followup. Based on this analysis, the clinical features of these tumors can be used to estimate the risk for tumor growth and metastases and assist the clinician with patient management.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Albert L. S., Sober A. J. Early detection of melanoma. Cancer Treat Res. 1993;65:57–67. doi: 10.1007/978-1-4615-3080-0_3. [DOI] [PubMed] [Google Scholar]
- Augsburger J. J., Gamel J. W. Clinical prognostic factors in patients with posterior uveal malignant melanoma. Cancer. 1990 Oct 1;66(7):1596–1600. doi: 10.1002/1097-0142(19901001)66:7<1596::aid-cncr2820660726>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
- Augsburger J. J., Schroeder R. P., Territo C., Gamel J. W., Shields J. A. Clinical parameters predictive of enlargement of melanocytic choroidal lesions. Br J Ophthalmol. 1989 Nov;73(11):911–917. doi: 10.1136/bjo.73.11.911. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Augsburger J. J., Vrabec T. R. Impact of delayed treatment in growing posterior uveal melanomas. Arch Ophthalmol. 1993 Oct;111(10):1382–1386. doi: 10.1001/archopht.1993.01090100090033. [DOI] [PubMed] [Google Scholar]
- Barr C. C., Sipperley J. O., Nicholson D. H. Small melanomas of the choroid. Arch Ophthalmol. 1978 Sep;96(9):1580–1582. doi: 10.1001/archopht.1978.03910060214005. [DOI] [PubMed] [Google Scholar]
- Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970 Nov;172(5):902–908. doi: 10.1097/00000658-197011000-00017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Butler P., Char D. H., Zarbin M., Kroll S. Natural history of indeterminate pigmented choroidal tumors. Ophthalmology. 1994 Apr;101(4):710–717. doi: 10.1016/s0161-6420(94)31274-7. [DOI] [PubMed] [Google Scholar]
- Butler P., Char D. H., Zarbin M., Kroll S. Natural history of indeterminate pigmented choroidal tumors. Ophthalmology. 1994 Apr;101(4):710–717. doi: 10.1016/s0161-6420(94)31274-7. [DOI] [PubMed] [Google Scholar]
- Char D. H., Hogan M. J. Management of small elevated pigmented choroidal lesions. Br J Ophthalmol. 1977 Jan;61(1):54–58. doi: 10.1136/bjo.61.1.54. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Clark W. H., Jr, From L., Bernardino E. A., Mihm M. C. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 1969 Mar;29(3):705–727. [PubMed] [Google Scholar]
- Davidorf F. H., Lang J. R. Small malignant melanomas of the choroid. Am J Ophthalmol. 1974 Nov;78(5):788–793. doi: 10.1016/0002-9394(74)90301-8. [DOI] [PubMed] [Google Scholar]
- Davidorf F. H. The melanoma controversy. A comparison of choroidal, cutaneous, and iris melanomas. Surv Ophthalmol. 1981 May-Jun;25(6):373–377. doi: 10.1016/0039-6257(81)90073-4. [DOI] [PubMed] [Google Scholar]
- Day C. L., Jr, Mihm M. C., Jr, Sober A. J., Fitzpatrick T. B., Malt R. A. Narrower margins for clinical stage I malignant melanoma. N Engl J Med. 1982 Feb 25;306(8):479–482. doi: 10.1056/NEJM198202253060810. [DOI] [PubMed] [Google Scholar]
- Diener-West M., Hawkins B. S., Markowitz J. A., Schachat A. P. A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol. 1992 Feb;110(2):245–250. doi: 10.1001/archopht.1992.01080140101036. [DOI] [PubMed] [Google Scholar]
- Ganley J. P., Comstock G. W. Benign nevi and malignant melanomas of the choroid. Am J Ophthalmol. 1973 Jul;76(1):19–25. doi: 10.1016/0002-9394(73)90003-2. [DOI] [PubMed] [Google Scholar]
- Gass J. D. Observation of suspected choroidal and ciliary body melanomas for evidence of growth prior to enucleation. Ophthalmology. 1980 Jun;87(6):523–528. doi: 10.1016/s0161-6420(80)35200-7. [DOI] [PubMed] [Google Scholar]
- Gragoudas E. S., Seddon J. M., Egan K. M., Polivogianis L., Hsieh C. C., Goitein M., Verhey L., Munzenrider J., Austin-Seymour M., Urie M. Prognostic factors for metastasis following proton beam irradiation of uveal melanomas. Ophthalmology. 1986 May;93(5):675–680. doi: 10.1016/s0161-6420(86)33699-6. [DOI] [PubMed] [Google Scholar]
- Greene M. H. The prevention of cutaneous malignant melanoma: high-risk groups, chemoprevention, education, and screening. Cancer Treat Res. 1993;65:103–140. doi: 10.1007/978-1-4615-3080-0_5. [DOI] [PubMed] [Google Scholar]
- Gruber S. B., Roush G. C., Barnhill R. L. Sensitivity and specificity of self-examination for cutaneous malignant melanoma risk factors. Am J Prev Med. 1993 Jan-Feb;9(1):50–54. [PubMed] [Google Scholar]
- Halpern A. C., Guerry D., 4th, Elder D. E., Clark W. H., Jr, Synnestvedt M., Norman S., Ayerle R. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study. Arch Dermatol. 1991 Jul;127(7):995–999. [PubMed] [Google Scholar]
- Jensen O. A. Malignant melanomas of the human uvea: 25-year follow-up of cases in Denmark, 1943--1952. Acta Ophthalmol (Copenh) 1982 Apr;60(2):161–182. doi: 10.1111/j.1755-3768.1982.tb08371.x. [DOI] [PubMed] [Google Scholar]
- Marrett L. D., King W. D., Walter S. D., From L. Use of host factors to identify people at high risk for cutaneous malignant melanoma . CMAJ. 1992 Aug 15;147(4):445–453. [PMC free article] [PubMed] [Google Scholar]
- McGovern V. J. The classification of melanoma and its relationship with prognosis. Pathology. 1970 Apr;2(2):85–98. doi: 10.3109/00313027009077330. [DOI] [PubMed] [Google Scholar]
- McLean I. W., Foster W. D., Zimmerman L. E., Martin D. G. Inferred natural history of uveal melanoma. Invest Ophthalmol Vis Sci. 1980 Jul;19(7):760–770. [PubMed] [Google Scholar]
- McLean M. J., Foster W. D., Zimmerman L. E. Prognostic factors in small malignant melanomas of choroid and ciliary body. Arch Ophthalmol. 1977 Jan;95(1):48–58. doi: 10.1001/archopht.1977.04450010050004. [DOI] [PubMed] [Google Scholar]
- Mims J. L., 3rd, Shields J. A. Follow-up studies of suspicious choroidal nevi. Ophthalmology. 1978 Sep;85(9):929–943. doi: 10.1016/s0161-6420(78)35597-4. [DOI] [PubMed] [Google Scholar]
- Murakami R., Tsukuma H., Kanamori S., Imanishi K., Otani T., Nakanishi K., Fujimoto I., Oshima A. Natural history of colorectal polyps and the effect of polypectomy on occurrence of subsequent cancer. Int J Cancer. 1990 Aug 15;46(2):159–164. doi: 10.1002/ijc.2910460203. [DOI] [PubMed] [Google Scholar]
- Packard R. B. In malignant choroidal melanoma will a delay in radical treatment influence prognosis? Trans Ophthalmol Soc U K. 1983;103(Pt 1):49–53. [PubMed] [Google Scholar]
- Rice R. P. Lowering death rates from colorectal cancer: challenge for the 1990s. Radiology. 1990 Aug;176(2):297–301. doi: 10.1148/radiology.176.2.2367642. [DOI] [PubMed] [Google Scholar]
- Sagebiel R. W. Cutaneous malignant melanoma--the party line and more--with a word on "safe sun". Compr Ther. 1993;19(5):225–231. [PubMed] [Google Scholar]
- Shammas H. F., Blodi F. C. Prognostic factors in choroidal and ciliary body melanomas. Arch Ophthalmol. 1977 Jan;95(1):63–69. doi: 10.1001/archopht.1977.04450010065005. [DOI] [PubMed] [Google Scholar]
- Thomas J. V., Green W. R., Maumenee A. E. Small choroidal melanomas. A long-term follow-up study. Arch Ophthalmol. 1979 May;97(5):861–864. doi: 10.1001/archopht.1979.01020010419001. [DOI] [PubMed] [Google Scholar]
- Winawer S. J., Zauber A. G., Ho M. N., O'Brien M. J., Gottlieb L. S., Sternberg S. S., Waye J. D., Schapiro M., Bond J. H., Panish J. F. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993 Dec 30;329(27):1977–1981. doi: 10.1056/NEJM199312303292701. [DOI] [PubMed] [Google Scholar]
- Zimmerman L. E., McLean I. W. Do growth and onset of symptoms of uveal melanomas indicate subclinical metastasis? Ophthalmology. 1984 Jun;91(6):685–691. doi: 10.1016/s0161-6420(84)34243-9. [DOI] [PubMed] [Google Scholar]
- Zimmerman L. E. Problems in the diagnosis of malignant melanomas of the choroid and ciliary body. The 1972 Arthur J. Bedell Lecture. Am J Ophthalmol. 1973 Jun;75(6):917–929. doi: 10.1016/0002-9394(73)91079-9. [DOI] [PubMed] [Google Scholar]